Condition
Human Cord Blood-derived Mononuclear Cells
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Human Cord Bloodderived Mononuclear Cells Hcbmncs
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Human Cord Bloodderived Mononuclear Cells Hcbmncs1
Active Sponsors
- Shandong Qilu Stem Cells Engineering Co., Ltd.1
- The First Affiliated Hospital with Nanjing Medical University1
Top Investigators
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Related Conditions
- Safety1
- Local Injection1
- Efficacy1
- Refractory Diabetic Foot1